Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis

Epirubicin (EPI) is one of the most used intravesical chemotherapy agents after transurethral resection to non-muscle invasive bladder tumors (NMIBC) to prevent cancer recurrence and progression. However, even after resection of bladder tumors and intravesical chemotherapy, half of them will recur a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncol Rep
Huvudupphovsmän: Chen, Jun-Feng, Yu, Bi-Xia, Yu, Rui, Ma, Liang, Lv, Xiu-Yi, Cheng, Yue, Ma, Qi
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2017
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355669/
https://ncbi.nlm.nih.gov/pubmed/28075465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5356
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk